MetaCap

CVS Health Earnings

NYSE: CVSConsumer StaplesRetail-Drug Stores and Proprietary StoresUSD

86.16-1.64 (-1.87%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Next earnings date

Wed, Nov 4, 2026

Before market open

Fiscal period

Sep/2026

EPS estimate

$1.62

CVS Health earnings summary

CVS Health is scheduled to report Sep/2026 earnings on Nov 4, 2026 before the market opens, with analysts expecting EPS of $1.62. In its most recent report on Aug 5, 2026 (Q2 2026), CVS posted EPS of $2.31. Revenue for the quarter was $106.10 billion.

Quarterly EPS is up 188.8% from the same quarter a year earlier. Across the last 16 reports, CVS shares moved an average of 2.5% (in either direction) in the first trading session after results, rising 7 times and falling 9 times.

Summary generated from market data by MetaCap's automated system. Methodology

CVS earnings history

CVS Health reported EPS versus estimates
Report dateEPS est.EPS actualSurprisePrice reaction
Aug 5, 2026—$2.31—+1.5%
May 6, 2026—$2.30—+5.9%
Feb 10, 2026—$2.31—-2.3%
Oct 29, 2025—$-3.13—+1.1%
Jul 31, 2025—$0.80—+4.9%
May 1, 2025—$1.41—-0.7%
Feb 12, 2025—$1.30—-3.6%
Nov 6, 2024—$0.07—-4.2%
Aug 7, 2024—$1.41—+2.2%
May 1, 2024—$0.88—-0.1%
Feb 7, 2024—$1.59—+1.0%
Nov 1, 2023—$1.75—-3.7%
Aug 2, 2023—$1.48—+2.7%
May 3, 2023—$1.65—-3.0%
Feb 8, 2023—$1.79—-1.2%
Nov 2, 2022—$-2.59—-2.0%

Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.

Related